Healthcare & Life Sciences Funding
Capvizr tracks Healthcare & Life Sciences funding activity across newly funded companies, lead investors, hiring signals, and market narratives.
Top company HeadspaceLargest round $3 billion620 deals
Recent Healthcare & Life Sciences rounds
- Fireside-backed Ace Blend in advanced talks for Series B fundraise · $40 million · Series B · June 12, 2026
- Remedy Science · $20 million · Series A · June 12, 2026
- OurMind · $2.1 million · Pre-Seed · June 12, 2026
- Gothenburg's Arkeon · $594 thousand · Pre-Seed · June 12, 2026
- Aton Health · an undisclosed amount · Series A · June 12, 2026
- SonoThera · $125 million · Series B · June 11, 2026
- GT Medical Technologies · $100 million · Series E · June 11, 2026
- CeQur · $100 million · Series E · June 11, 2026
- QubeHealth-Pay · $55 million · Series A · June 11, 2026
- Uncovr · $7 million · Seed · June 11, 2026
Market context
Healthcare & Life Sciences deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.
Open Healthcare & Life Sciences in the interactive Capvizr dashboard →